CN115362128A - 硅酸盐基质和稀土类化合物的复合体、发光纳米颗粒、细胞的检测方法、动物的治疗方法、医疗装置以及硅酸盐基质和稀土类化合物的复合体的制造方法 - Google Patents

硅酸盐基质和稀土类化合物的复合体、发光纳米颗粒、细胞的检测方法、动物的治疗方法、医疗装置以及硅酸盐基质和稀土类化合物的复合体的制造方法 Download PDF

Info

Publication number
CN115362128A
CN115362128A CN202180021205.6A CN202180021205A CN115362128A CN 115362128 A CN115362128 A CN 115362128A CN 202180021205 A CN202180021205 A CN 202180021205A CN 115362128 A CN115362128 A CN 115362128A
Authority
CN
China
Prior art keywords
rare earth
silicate matrix
diffraction peak
earth compound
diffraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180021205.6A
Other languages
English (en)
Chinese (zh)
Inventor
茶谷直
犬井正彦
多贺谷基博
片冈卓也
本塚智
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohara Inc
Nagaoka University of Technology
Institute of National Colleges of Technologies Japan
Original Assignee
Ohara Inc
Nagaoka University of Technology
Institute of National Colleges of Technologies Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohara Inc, Nagaoka University of Technology, Institute of National Colleges of Technologies Japan filed Critical Ohara Inc
Publication of CN115362128A publication Critical patent/CN115362128A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
    • C09K11/08—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials
    • C09K11/77—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials containing rare earth metals
    • C09K11/7728—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials containing rare earth metals containing europium
    • C09K11/77342—Silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B33/00—Silicon; Compounds thereof
    • C01B33/113—Silicon oxides; Hydrates thereof
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
    • C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent materials, e.g. electroluminescent or chemiluminescent
    • C09K11/08—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials
    • C09K11/77—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials containing rare earth metals
    • C09K11/7728—Luminescent materials, e.g. electroluminescent or chemiluminescent containing inorganic luminescent materials containing rare earth metals containing europium
    • C09K11/7732—Halogenides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/552—Glass or silica
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/587—Nanoparticles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Nanotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biophysics (AREA)
  • Luminescent Compositions (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Radiation-Therapy Devices (AREA)
  • Silicon Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
CN202180021205.6A 2020-03-17 2021-03-16 硅酸盐基质和稀土类化合物的复合体、发光纳米颗粒、细胞的检测方法、动物的治疗方法、医疗装置以及硅酸盐基质和稀土类化合物的复合体的制造方法 Pending CN115362128A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020-046605 2020-03-17
JP2020046605A JP7515137B2 (ja) 2020-03-17 2020-03-17 ケイ酸塩系基材と希土類化合物との複合体、発光ナノ粒子、細胞の検出方法、動物の治療方法、医療装置、及びケイ酸塩系基材と希土類化合物との複合体の製造方法
PCT/JP2021/010645 WO2021187492A1 (ja) 2020-03-17 2021-03-16 ケイ酸塩系基材と希土類化合物との複合体、発光ナノ粒子、細胞の検出方法、動物の治療方法、医療装置、及びケイ酸塩系基材と希土類化合物との複合体の製造方法

Publications (1)

Publication Number Publication Date
CN115362128A true CN115362128A (zh) 2022-11-18

Family

ID=77771019

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180021205.6A Pending CN115362128A (zh) 2020-03-17 2021-03-16 硅酸盐基质和稀土类化合物的复合体、发光纳米颗粒、细胞的检测方法、动物的治疗方法、医疗装置以及硅酸盐基质和稀土类化合物的复合体的制造方法

Country Status (5)

Country Link
US (1) US20230142721A1 (cg-RX-API-DMAC10.html)
EP (1) EP4122886B1 (cg-RX-API-DMAC10.html)
JP (1) JP7515137B2 (cg-RX-API-DMAC10.html)
CN (1) CN115362128A (cg-RX-API-DMAC10.html)
WO (1) WO2021187492A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7554424B2 (ja) 2020-03-17 2024-09-20 株式会社オハラ ユーロピウム化合物の結晶体及びユーロピウム化合物の結晶体の製造方法
CN114295664A (zh) * 2021-12-16 2022-04-08 中国煤炭地质总局勘查研究总院 一种利用阴极发光检测矿物中稀土元素的方法
CN120769988A (zh) * 2023-02-24 2025-10-10 株式会社小原 蛋白质固定化用载体、蛋白质固定化用载体分散液、蛋白质固定化用载体水合物、蛋白质担载复合体以及抗体试剂盒

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101641288B (zh) * 2007-03-27 2013-07-03 扶桑化学工业株式会社 胶态二氧化硅及其制造方法
KR100943839B1 (ko) 2007-10-31 2010-02-24 한국과학기술연구원 불규칙 표면구조의 우선 도입에 의해 고수율의바이오-이미지용 나노입자를 제조하는 방법
JP2009190976A (ja) 2008-02-12 2009-08-27 Univ Of Tokyo 水分散性量子ドット
JP2010133887A (ja) 2008-12-08 2010-06-17 Yamaguchi Univ 水溶性高効率二光子吸収材料
GB2478307A (en) * 2010-03-02 2011-09-07 Heraeus Quartz Uk Ltd Manufacture of silica glass
JP2013014651A (ja) 2011-07-01 2013-01-24 Tokyo Institute Of Technology 蛍光粒子およびその製造方法
JP5790352B2 (ja) 2011-09-09 2015-10-07 コニカミノルタ株式会社 蛍光物質内包ナノ粒子およびこれを用いた生体物質の検出方法
JP6474212B2 (ja) * 2014-08-19 2019-02-27 学校法人東京理科大学 中空シリカ粒子の製造方法及び中空シリカ粒子
JP6820154B2 (ja) 2016-03-28 2021-01-27 株式会社オハラ 発光ナノ粒子、それを用いた細胞の検出方法、動物の治療方法、医療装置、細胞の可視化方法、及び細胞の損傷軽減方法
CN107311217B (zh) * 2017-07-24 2020-02-18 吉林大学 一种磁性/荧光双功能的EuCl2纳米晶以及超晶格结构的EuCl2纳米晶
JP7259231B2 (ja) * 2018-08-31 2023-04-18 堺化学工業株式会社 粒子状シリカ及びその製造方法

Also Published As

Publication number Publication date
EP4122886A1 (en) 2023-01-25
JP7515137B2 (ja) 2024-07-12
EP4122886A4 (en) 2024-03-20
EP4122886B1 (en) 2025-09-03
US20230142721A1 (en) 2023-05-11
JP2021147255A (ja) 2021-09-27
WO2021187492A1 (ja) 2021-09-23

Similar Documents

Publication Publication Date Title
CN115554992B (zh) 一种聚合物修饰的磁性纳米材料、其制备方法及应用
US9265729B2 (en) Nanofunctional silica particles and manufacturing method thereof
US20230114986A1 (en) Light-emitting nanoparticles, cell detection method using same, animal treatment method, medical device, cell visualization method, and method for reducing injury to cell
Singh et al. Development of biocompatible apatite nanorod-based drug-delivery system with in situ fluorescence imaging capacity
WO2007142316A1 (ja) 新規なナノシリカ粒子の製造方法と用途
EP4122886B1 (en) Complex between silicate-based substrate and rare earth element compound, light-emitting nano particles, cell detection method, and method for producing complex between silicate-based substrate and rare earth element compound
Markova et al. Synthesis and properties of core–shell fluorescent hybrids with distinct morphologies based on carbon dots
WO2010016289A1 (ja) 量子ドットを含有する蛍光標識剤
Fan et al. Dual CEA/CD44 targeting to colorectal cancer cells using nanobody-conjugated hyaluronic acid-modified mesoporous silica nanoparticles with pH-and redox-sensitivity
Phuong et al. SCN–IgG functionalized NaYF4: Yb3+/(Er3+, Tm3+) upconversion nanoparticles for targeted fluorescence imaging of liver cancer cells
Lakshmi et al. Bone tissue regeneration potential of Tb³⁺ ion-integrated silico-gallate mesoporous bioactive glasses
CN111253932A (zh) 一种基于荧光碳点、共掺杂纳米晶的比率型荧光探针及其制备方法和应用
CN111303877A (zh) 量子点荧光探针在细胞中和人体血液Hg2+可视化检测中的应用
Fan et al. Polyacrylic Acid-Ca2+ (Ce3+) Nanoclusters as Fluorescent “Off–On–Off” Probes for Quantitative Detection of Pyrophosphate and Alkaline Phosphatase
Fang et al. Highly stable folic acid functionalized copper-nanocluster/silica nanoparticles for selective targeting of cancer cells
WO2010004777A1 (ja) 無機ナノ粒子標識剤
JP5168092B2 (ja) 半導体ナノ粒子標識剤
US12276039B2 (en) Crystal of europium compound and method for producing crystal of europium compound
WO2012128162A1 (ja) 画像診断用シリカナノ粒子、その製造方法、及び生体物質標識剤
JP7096557B2 (ja) 発光ナノ粒子、それを用いた細胞の検出方法、動物の治療方法、医療装置、細胞の可視化方法、及び細胞の損傷軽減方法
CN116656340B (zh) 一种荧光纳米材料及其制备方法与应用
CN116970387A (zh) 一种检测水解奶粉的复合纳米材料及其制备方法与应用
片岡卓也 Study on Synthesis of Luminescent Hydroxyapatite Nanoparticles and Their Surface Functionalization for Cell Labeling Applications
CN108587630A (zh) 近红外荧光发射水溶性ZnXSe量子点及其制备方法
dos Santos Neves Development of fluorescent silica nanoparticles encapsulating organic and inorganic fluorophores; synthesis and characterization

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination